Tumour cell PD-L1 expression by immunohistochemistry is an established predictive biomarker for PD-(L)1 treatment of non-small cell lung cancer97 but does not appear to consistently correlate with response in many other tumours including HCC. The gene discussed is CD274; the disease is hepatocellular carcinoma.